XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,499,000) $ (235,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities    
Depreciation and amortization 345,000 279,000
Issuance of common stock for consulting services 60,000
Equity compensation charge 160,000 21,000
Non-cash interest and fees 116,000 103,000
Change in assets and liabilities:    
Accounts receivable (1,428,000) (2,357,000)
Inventories (702,000) 534,000
Prepaid expenses and other assets (80,000) 57,000
Trade payables 620,000 (396,000)
Advance investor deposit 1,050,000 1,500,000
Accrued liabilities 84,000 (728,000)
Net cash (used in) provided by operating activities (1,274,000) (1,222,000)
Cash flows from investing activities:    
Purchases of property, plant and equipment (331,000) (221,000)
Net cash (used in) provided by investing activities (331,000) (221,000)
Cash flows from financing activities:    
Receipt for preferred stock issuance 500,000
Repayment of note payable, related party (1,000,000)
Net advances (repayments) of term loan (183,000) 105,000
Net advances (repayments) on revolving line of credit 1,587,000 2,113,000
Net cash provided by (used in) financing activities 904,000 2,218,000
Net increase (decrease) in cash and cash equivalents (701,000) 775,000
Cash and cash equivalents at beginning of year 921,000 146,000
Cash and cash equivalents at end of year 220,000 921,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:    
Cash payments for interest 862,000 551,000
Accretion of dividends on preferred stock 143,000 11,000
Common stock issued in exchange for assets acquired 6,250,000
Allocation of proceeds from preferred stock financing to the issuance of warrants for common stock 814,000
Reclassification of investor advances upon issuances of preferred stock 1,500,000
Adjustment to right-of-use asset and lease liability upon extension 1,130,000
Conversion of notes and liabilities into common stock 1,200,000
Conversion of preferred stock into common stock $ 1,862,000